BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 32912113)

  • 1. Suppression of miR-661 inhibits the metastasis of hepatocellular carcinoma.
    Wang J; Yu Z; Ma H; Zhang G
    Asian J Surg; 2024 May; 47(5):2491-2493. PubMed ID: 38281832
    [No Abstract]   [Full Text] [Related]  

  • 2. Two important players in poor-prognosis hepatocellular carcinoma: Extrachromosomal circular DNA (eccDNA) and its passenger, the oncogenic miR-17~92 locus.
    Andrisani O
    Hepatology; 2024 Jan; 79(1):6-8. PubMed ID: 37183875
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of Dhx15 as a Major Regulator of Liver Development, Regeneration, and Tumor Growth in Zebrafish and Mice.
    Portolés I; Ribera J; Fernandez-Galán E; Lecue E; Casals G; Melgar-Lesmes P; Fernández-Varo G; Boix L; Sanduzzi M; Aishwarya V; Reig M; Jiménez W; Morales-Ruiz M
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma.
    Todorović L; Stanojević B
    Biomol Biomed; 2023 Feb; 23(1):26-36. PubMed ID: 36036061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression.
    Teng D; Xia S; Hu S; Yan Y; Liu B; Yang Y; Du X
    Comput Intell Neurosci; 2022; 2022():7179733. PubMed ID: 35795731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-887 Promotes the Progression of Hepatocellular Carcinoma via Targeting VHL.
    Zou W; Cheng J
    Technol Cancer Res Treat; 2020; 19():1533033820940425. PubMed ID: 32912113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [LncRNA HULC promots HCC growth by downregulating miR-29].
    Zhu LR; Feng JL; Liu XJ; Wang JM
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
    [No Abstract]   [Full Text] [Related]  

  • 8. MicroRNA-493 suppresses cell proliferation and invasion by targeting ZFX in human hepatocellular carcinoma.
    Ding W; Tan H; Li X; Zhang Y; Fang F; Tian Y; Li J; Pan X
    Cancer Biomark; 2018; 22(3):427-434. PubMed ID: 29758928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa-miR-331-3p inhibits VHL expression by directly targeting its mRNA 3'-UTR in HCC cell lines.
    Cao Y; Zhang J; Xiong D; Wang D; Wu T; Huang A; Tang H
    Acta Biochim Pol; 2015; 62(1):77-82. PubMed ID: 25750939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5.
    Yao B; Li Y; Niu Y; Wang L; Chen T; Guo C; Liu Q
    J Cell Mol Med; 2020 Aug; 24(15):8718-8731. PubMed ID: 32596968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
    Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
    Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.
    Vasuri F; Visani M; Acquaviva G; Brand T; Fiorentino M; Pession A; Tallini G; D'Errico A; de Biase D
    World J Gastroenterol; 2018 Jul; 24(25):2647-2660. PubMed ID: 29991871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VHL and Hypoxia Signaling: Beyond HIF in Cancer.
    Zhang J; Zhang Q
    Biomedicines; 2018 Mar; 6(1):. PubMed ID: 29562667
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.